Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6242
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence ; volume:21 ; number:10 ; day:27 ; month:7 ; year:2019 ; pages:1-8 ; date:10.2019
Current atherosclerosis reports ; 21, Heft 10 (27.7.2019), 1-8, 10.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11883-019-0800-z
- URN
-
urn:nbn:de:101:1-2020012219383689752479
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Matthew M. Y.
- Sattar, Naveed
- McMurray, John J. V.
- Packard, Chris J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Vitamin D and COVID-19 infection and mortality in UK Biobank
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
Excess risk of hospitalisation for heart failure among people with type 2 diabetes
The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis
Weight gain leads to greater adverse metabolic responses in South Asian compared with white European men: the GlasVEGAS study
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Vitamin D and COVID-19 infection and mortality in UK Biobank
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
Excess risk of hospitalisation for heart failure among people with type 2 diabetes
The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis
Weight gain leads to greater adverse metabolic responses in South Asian compared with white European men: the GlasVEGAS study
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease
Metabolic characterization of menopause: cross-sectional and longitudinal evidence
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health Care
Appetite and its Regulation: Are there Palatable Interventions for Heart Failure?
Vitamin D and COVID-19 infection and mortality in UK Biobank
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
Effect of race on cardiometabolic responses to once-weekly exenatide: insights from the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register
Excess risk of hospitalisation for heart failure among people with type 2 diabetes
The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis
Weight gain leads to greater adverse metabolic responses in South Asian compared with white European men: the GlasVEGAS study
Association of maternal diabetes/glycosuria and pre-pregnancy body mass index with offspring indicators of non-alcoholic fatty liver disease